Dorman (DORM) Form 144: Proposed sale of 9,191 shares; prior insider sale noted

Rhea-AI Filing Summary

Dorman Products, Inc. (DORM) Form 144 reports a proposed sale of 9,191 common shares with an aggregate market value of $1,365,166.37, against approximately 30,534,243 shares outstanding, with an approximate sale date of 08/12/2025 on NASDAQ.

The notice details how the securities were acquired: restricted stock vesting (1,005; 1,987; 575 shares on 02/20/2025, 02/28/2025, 03/04/2025) and option-related acquisitions reported on 08/12/2025 (1,018; 1,998; 1,477; 1,131 shares) with payment described as compensation or cash. The filing also discloses a recent sale on 08/11/2025 by Jeffrey Darby of 2,231 shares for $317,597.63. The filer attests to having no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Form 144 shows a modest planned insider sale; the size is immaterial relative to shares outstanding.

The filing reports a proposed sale of 9,191 shares valued at $1,365,166.37 versus 30,534,243 shares outstanding, representing roughly 0.03% of the outstanding shares. That scale is unlikely to be market-moving. The filing is routine in format and includes prior vesting and option-related acquisitions, which explain the source of the shares. From a trading-flow perspective, the disclosed size and recent insider sale (2,231 shares) point to personal liquidity events rather than a material change in company fundamentals.

Corporate Governance Expert

TL;DR: Transactions arise from compensation vesting and option exercises; the Form 144 complies with Rule 144 disclosure conventions.

The notice itemizes restricted stock vesting and option-originated shares with payment types listed as compensation or cash, and it discloses a recent separate sale by Jeffrey Darby. The filing includes the standard attestation that no material undisclosed information is known by the filer. These elements indicate procedural compliance with insider-reporting rules rather than governance events that would materially affect shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9191	1365166.37	30534243	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2025	Restricted Stock Vesting	Issuer			1005	02/20/2025	Compensation
Common	02/28/2025	Restricted Stock Vesting	Issuer			1987	02/28/2025	Compensation
Common	03/04/2025	Restricted Stock Vesting	Issuer			575	03/04/2025	Compensation
Common	08/12/2025	Option Granted - 03/06/2019	Issuer			1018	08/12/2025	Cash
Common	08/12/2025	Option Granted - 03/02/2021	Issuer			1998	08/12/2025	Cash
Common	08/12/2025	Option Granted - 03/02/2022	Issuer			1477	08/12/2025	Cash
Common	08/12/2025	Option Granted - 03/02/2023	Issuer			1131	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeffrey Darby 3400 East Walnut Street Colmar PA 18915	Common	08/11/2025	2231	317597.63

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DORM Form 144 disclose about the proposed sale?

The filing shows a proposed sale of 9,191 common shares with an aggregate market value of $1,365,166.37, planned for 08/12/2025 on NASDAQ.

How many shares outstanding are reported in the filing for DORM?

The Form 144 lists 30,534,243 shares outstanding.

What were the sources of the securities to be sold according to the filing?

Sources include restricted stock vesting (1,005; 1,987; 575 shares on 02/20/2025, 02/28/2025, 03/04/2025) and option-related acquisitions (1,018; 1,998; 1,477; 1,131 shares reported on 08/12/2025) with payment described as compensation or cash.

Did any insider sale occur recently according to the filing?

Yes. The filing discloses that Jeffrey Darby sold 2,231 shares on 08/11/2025 for $317,597.63.

Does the filer assert possession of undisclosed material information?

The filer represents by signing the notice that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.